Search - tctmd.com

Displaying 321 - 340 of 507

Sort: Relevancy | Date

Presentation NY Valves 2024

Case Presentation: M-TEER in Commissural Disease: Device Selection and Procedural Considerations

Presenter: Sam Dawkins

June 05, 2024

Presentation NY Valves 2024

Case Presentation: M-TEER in a Small Left Atrium: Device Selection and Procedural Considerations

Presenter: Tom Cahill

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Unraveling Post-M-TEER Gradients: Evaluating Risk of Mitral Stenosis

Presenter: Masahiko Asami

June 05, 2024

Presentation NY Valves 2024

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Presenter: Amar Krishnaswamy

June 05, 2024

News Daily News

Pollution Deserves More Attention in Cardiology—and More Action

Yael L. Maxwell

June 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Conference News HRS 2024

LEADR: Small Diameter ICD Lead Meets Efficacy and Safety Thresholds

L.A. McKeown

May 27, 2024

News Conference News EuroPCR 2024

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

Caitlin E. Cox

May 24, 2024

News Conference News HRS 2024

Aveir DR Dual-Chamber Leadless Pacemaker Looks Solid at 1 Year

Todd Neale

May 23, 2024

News Conference News ESOC 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

Todd Neale

May 22, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Caitlin E. Cox

May 16, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Advertisement

Case Presentation: M-TEER in Commissural Disease: Device Selection and Procedural Considerations

Case Presentation: M-TEER in a Small Left Atrium: Device Selection and Procedural Considerations

Case Presentation: Unraveling Post-M-TEER Gradients: Evaluating Risk of Mitral Stenosis

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Pollution Deserves More Attention in Cardiology—and More Action

TCTMD’s Top 10 Most Popular Stories for May 2024

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

LEADR: Small Diameter ICD Lead Meets Efficacy and Safety Thresholds

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

Aveir DR Dual-Chamber Leadless Pacemaker Looks Solid at 1 Year

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content